Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy. The SYDNEY 2 trial. - Ziegler,D.; Ametov,A.; Barinov,A.; Dyck,PJ.; Gurieva,I.; Low,PA.; Munzel,U.; Yakhno,N.; Raz,I.; Novosadova,M.; Maus,J.; Samigullin,R. (Diabetes Care, 2006)